secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0000721371-24-000119
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q1 GAAP EPS $1.70; Non-GAAP EPS $1.88, up 9% YoY; Raises FY25 guidance
--------------------------------------------------------------------------------

- Revenue $52.3B, down 4% (up 15% ex-large customer expiration); Pharmaceutical segment profit up 16% to $530M.
- Non-GAAP operating earnings $625M (+12%) driven by brand/specialty growth and early COVID vaccine distribution.
- Non-GAAP diluted EPS guidance raised to $7.75-$7.90 from $7.55-$7.70; adjusted free cash flow outlook now $1.0B-$1.5B.
- Announced $1.1B cash acquisition of Integrated Oncology Network, adding 100+ providers across 10 states.
- Completed $375M accelerated share repurchase in October; Global Medical Products segment profit fell to $8M from $12M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000119/0000721371-24-000119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137124000119/cah-20241101.htm
  HTML page:      https://secwatch.observer/filing/0000721371-24-000119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer